PTGX Protagonist Therapeutics, Inc. Total Asset Value of Company
The total asset value of Protagonist Therapeutics (PTGX) correlates with the plans to bring rusfertide to market and the receipt of royalties from J&J. The value of 801.84 characterizes this level, while unique blood peptides ensure long-term financial stability. Meanwhile, the current cash inflow is based on interim partner payments rather than systemic sales.
Analytical breakdowns and data insights for company Protagonist Therapeutics Inc (PTGX)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
All Debt to Shareholders' Equity Ratio Protagonist Therapeutics|PTGX - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Protagonist Corp|PTGX - Company Aggregate Debts|Debts to Book Capitalization Protagonist Corp|PTGX - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Protagonist Therapeutics|Interim Coverage Ratio protagonist-inc.com
- net income and valuation multiples indicators:
Fundamental valuation:Protagonist Therapeutics
For Protagonist Therapeutics (PTGX), whose operations focus on the development of peptide drugs, the total volume of resources determines the potential for implementing innovative developments. By analyzing the organization's asset level, calculated inversely through return on assets (ROA), an investor assesses the balance between equity and liabilities, where excessive growth signals inefficient liquidity management, while a sharp reduction indicates the risk of clinical trials being halted.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|IMVT (Immunovant Therapeutics) - Aggregate Asset Value|Company Total Assets KNSA (Kiniksa Pharmaceuticals)|Company Total Assets grifols.com GRFS|ADPT - Aggregate Company Assets|Aggregate Asset Value CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Aggregate Company Assets|Cumulative Company Assets BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Company Total Assets|Company Total Assets dianthustx.com|Cumulative Company Assets PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Aggregate Asset Value|Company Total Assets TRML (Tourmaline Corp)|Company Total Asset Base Precigen Corp (PGEN)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|RIGL - Aggregate Company Assets|Total Asset Value of Company ANAB|Astria Therapeutics (ATXS) - Aggregate Company Assets|engene.com - Aggregate Asset Value|Aggregate Company Assets RAPT Therapeutics|Company Assets Aerovate JBIO|Cumulative Company Assets ACRS (Aclaris)|Aggregate Business Assets KYTX|Company Total Assets TLSA (Tiziana Life Sciences)|Company Total Assets cabalettabio.com CABA|Ventyx Biosciences, Inc. - Company Total Assets|Company Balance Sheet Assets Theratechnologies, Inc. (THTX)|Avalo Therapeutics Inc. (AVTX) - Aggregate Company Assets|Company Assets Eledon Pharmaceuticals, Inc (ELDN)|Aggregate Company Assets Agenus|Total Business Assets CLYM (climbbio.com)|Company Total Assets ZURA|Company Total Asset Base aTyr Pharma Inc|Aggregate Company Assets Adagene Inc. ADAG|Company Total Asset Base ImageneBio (IMA)|STTK: Cumulative Company Assets|Equillium, Inc. - Aggregate Business Assets|CNTB (connectbiopharm.com) - Cumulative Company Assets|Immunic - Aggregate Asset Value|Cumulative Company Assets ATRA|IFRX (InflaRx GmbH) - Aggregate Business Assets|Company Total Assets XFOR|ACET (adicetbio.com) - Aggregate Asset Value|Company Total Assets CELU (Celularity)|INmune Bio Inc (INMB) - Company Assets|BRNS - Aggregate Company Assets|Aggregate Asset Value KZR (Kezar Life Sciences Inc)|SABS: Company Total Assets|akaritx.com (AKTX) - Company Total Assets|Aggregate Company Assets Enlivex Therapeutics Ltd|Q32 Bio Corp - Total Asset Value of Company|Company Total Assets GOVX|EDSA - Company Assets|iBio, Inc. - Cumulative Company Assets|Company Total Assets Carisma Therapeutics Inc CARM|XTLB: Cumulative Company Assets|Bolt Biotherapeutics - Aggregate Business Assets|HCWB: Company Total Assets|APVO - Company Total Asset Base|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Cumulative Company Assets Aditxt Corp (ADTX)|Aggregate Company Assets GRI Bio (GRI)|Company Total Asset Base XORTX Therapeutics Inc|Aggregate Company Assets ReShape Lifesciences HIND|REVB (Revelation Biosciences Corp) - Total Asset Value of Company|INDP: Cumulative Company Assets|scinai.com - Aggregate Business Assets|CALI: Company Total Assets|Company Balance Sheet Assets Affimed N.V. AFMD|Cumulative Company Assets ALLK|Total Business Assets HOOK (HOOKIPA)|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|ITOS: Total Asset Value of Company|Company Total Assets OCEA (Ocean Biomedical)|Aggregate Asset Value TCBP|Third Harmonic Bio, Inc - Company Total Assets